查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1644217

全球强度调控放射治疗市场

Intensity Modulated Radiation Therapy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 160 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球强度调控放射治疗市场规模将达到 35 亿美元

2024 年全球强度调控放射治疗估计为 26 亿美元，预计到 2030 年将达到 35 亿美元，2024-2030 年分析期间的复合年增长率为 4.7%。电子束治疗是该报告分析的领域之一，预计其复合年增长率为 4.7%，到分析期结束时将达到 13 亿美元。预计在分析期内，碳离子放射线治疗领域的复合年增长率为 4.0%。

美国市场规模估计为 6.911 亿美元，中国市场预计年均成长率为 4.7%

预计 2024 年美国强度调控放射治疗市场价值将达 6.911 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 5.597 亿美元，2024-2030 年分析期间的复合年增长率为 4.7%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 4.4% 和 4.2%。在欧洲，德国的复合年增长率预计为 4.0%。

全球强度调控放射治疗市场-主要趋势与驱动因素摘要

为什么强度调控放射治疗会改变癌症治疗？

强度调控放射治疗(IMRT) 在瞄准肿瘤方面具有无与伦比的精确度，同时最大限度地减少了对周围健康组织的损害，并已成为晚期癌症治疗的基石。这项创新技术透过调节辐射束的强度，能够提供高度适形的辐射剂量，使其在治疗复杂和形状不规则的肿瘤方面特别有效。随着全球癌症发生率持续上升，与传统放射疗法相比，IMRT 可以改善治疗效果并减少副作用，因此正成为肿瘤内科医师的首选。 IMRT 对于治疗位于重要器官附近的癌症特别有益，例如头颈癌、前列腺癌和脑肿瘤。其高精度可减少併发症并保留敏感区域的功能，从而显着改善患者的生活品质。此外，随着越来越多的医疗保健提供者和癌症治疗中心将 IMRT 纳入其治疗中，其应用范围和采用范围正在扩大。对以患者为中心的护理的日益关注以及对先进的非侵入性治疗方案的需求不断增长，推动了 IMRT 在已开发和新兴医疗保健市场的广泛应用。

科技进步如何增强 IMRT 能力？

IMRT 领域取得了重大技术进步，进一步巩固了其作为放射肿瘤学领先治疗方法的地位。影像导航放射治疗(IGRT) 与 IMRT 的结合透过结合考虑肿瘤运动和患者位置的即时成像显着提高了治疗精度。这种组合可以将辐射精确地传送到预定目标，即使是在肺部和腹部等动态解剖区域。此外，治疗计划软体和机器学习演算法的进步使得放射治疗更加个人化和适应性强。这些创新使临床医生能够根据患者的个别特征、肿瘤生物学和治疗反应来制定治疗方案。此外，自动化治疗计划系统的采用减少了开发复杂 IMRT通讯协定所需的时间，提高了肿瘤中心的业务效率。此外，质子治疗与IMRT等新技术的结合，使得治疗更加精准，为儿童及难治性癌症的治疗开闢了新的前景。

IMRT 应用的主要市场趋势是什么？

从大型肿瘤中心到小型社区医院，IMRT 的应用正在各种医疗保健环境中迅速扩大。在北美、欧洲等已开发地区，完善的医疗基础设施和优惠的报销政策促进了IMRT的广泛应用。此外，由于生活方式相关癌症的增加和人口老化，这些地区对先进放射治疗技术的需求激增。由于医疗保健投入的增加和对晚期癌症治疗方案的认识不断提高，新兴市场，尤其是亚太地区，对 IMRT 的采用显着增加。中国和印度等国家的政府优先建立配备调强放射治疗（IMRT）等最尖端科技的专门癌症治疗中心，以应对该地区日益严重的癌症负担。此外，私人医疗保健提供者越来越多地与提供尖端IMRT解决方案的技术供应商合作，以提高这些地区的肿瘤治疗品质。

哪些因素将推动IMRT市场的成长？

IMRT市场的成长受到多种因素的推动，包括全球癌症发生率的增加、精准医疗的需求不断增长以及放射治疗技术的进步。提高对IMRT在减少治疗相关併发症和提高存活率方面益处的认识是市场成长的主要动力。此外，旨在改善晚期癌症治疗机会的政府支持政策和资助措施在扩大市场方面发挥重要作用。最终用途趋势也影响市场，医院、癌症治疗中心和专科放射肿瘤诊所是 IMRT 的主要使用者。人们对门诊癌症治疗的偏好日益增长，进一步推动了对紧凑、经济高效的 IMRT 系统的需求。同时，远端医疗和远端医疗计画的进步使得IMRT在医疗资源匮乏的地区更加广泛地普及，解决了癌症治疗的地理差异问题。综合起来，这些因素强调了 IMRT 在彻底改变癌症治疗以及满足全球患者和医疗保健提供者不断变化的需求方面的战略重要性。

部分

辐射类型（电子辐射、碳离子辐射、光子辐射、质子辐射）、应用（乳腺癌应用、前列腺癌应用、妇科癌症应用、肺癌应用、脑肿瘤应用、其他应用）

受访公司范例（52家值得关注的公司）

  • Accuray, Inc.
  • Brainlab AG
  • Elekta AB
  • IBA Dosimetry GmbH
  • Mevion Medical Systems, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Protom International
  • RAYSEARCH Laboratories AB
  • Reflexion Medical, Inc.
  • Siemens Healthineers AG

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP31654

Global Intensity Modulated Radiation Therapy Market to Reach US$3.5 Billion by 2030

The global market for Intensity Modulated Radiation Therapy estimated at US$2.6 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Electron Radiation Therapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Carbon-Ion Radiation Therapy segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$691.1 Million While China is Forecast to Grow at 4.7% CAGR

The Intensity Modulated Radiation Therapy market in the U.S. is estimated at US$691.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$559.7 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Intensity Modulated Radiation Therapy Market - Key Trends & Drivers Summarized

Why Is Intensity Modulated Radiation Therapy Transforming Cancer Treatment?

Intensity Modulated Radiation Therapy (IMRT) has emerged as a cornerstone in advanced cancer treatment, offering unparalleled precision in targeting tumors while minimizing damage to surrounding healthy tissues. This innovative technology allows for the delivery of highly conformal radiation doses by modulating the intensity of radiation beams, making it particularly effective in treating complex and irregularly shaped tumors. As cancer prevalence continues to rise globally, IMRT is becoming a preferred choice for oncologists due to its ability to improve treatment outcomes and reduce side effects compared to traditional radiation therapies. IMRT is especially beneficial in treating cancers located near critical organs, such as head and neck cancers, prostate cancer, and brain tumors. Its precision has significantly enhanced the quality of life for patients by reducing complications and preserving functionality in sensitive areas. Furthermore, as more healthcare providers and cancer treatment centers integrate IMRT into their offerings, its accessibility and adoption have expanded. The growing focus on patient-centric care and the increasing demand for advanced, non-invasive treatment options are driving the widespread adoption of IMRT across developed and emerging healthcare markets.

How Are Technological Advancements Enhancing IMRT’s Capabilities?

The field of IMRT has witnessed remarkable technological advancements, further cementing its position as a leading modality in radiation oncology. The integration of image-guided radiation therapy (IGRT) with IMRT has significantly improved the accuracy of treatment delivery by incorporating real-time imaging to account for tumor movement and patient positioning. This combination ensures that radiation is delivered precisely to the intended target, even in dynamic anatomical regions such as the lungs and abdomen. Additionally, advancements in treatment planning software and machine learning algorithms are enabling more personalized and adaptive radiation therapy. These innovations allow clinicians to tailor treatments based on individual patient characteristics, tumor biology, and response to therapy. The adoption of automated treatment planning systems is also reducing the time required to develop complex IMRT protocols, enhancing operational efficiency in oncology centers. Furthermore, emerging technologies such as proton therapy are being integrated with IMRT to provide even greater precision, opening new frontiers in the treatment of pediatric and hard-to-treat cancers.

What Are the Key Market Trends in the Adoption of IMRT?

The adoption of IMRT is growing rapidly across diverse healthcare settings, from large oncology centers to smaller community hospitals. In developed regions such as North America and Europe, well-established healthcare infrastructures and favorable reimbursement policies have facilitated the widespread implementation of IMRT. These regions are also witnessing a surge in demand for advanced radiation therapy technologies due to the increasing prevalence of lifestyle-related cancers and aging populations. Emerging markets, particularly in Asia-Pacific, are experiencing a significant uptick in IMRT adoption due to rising healthcare investments and growing awareness of advanced cancer treatment options. Governments in countries like China and India are prioritizing the establishment of specialized cancer treatment centers equipped with state-of-the-art technologies like IMRT to address the region’s burgeoning cancer burden. Moreover, private healthcare providers are increasingly partnering with technology vendors to offer cutting-edge IMRT solutions, enhancing the quality of oncology care in these regions.

What Factors Are Driving the Growth of the IMRT Market?

The growth in the Intensity Modulated Radiation Therapy market is driven by several factors, including the increasing global burden of cancer, the rising demand for precision medicine, and advancements in radiation therapy technologies. The growing awareness of the benefits of IMRT in reducing treatment-related complications and improving survival rates is a key driver of market growth. Additionally, supportive government policies and funding initiatives aimed at improving access to advanced cancer treatments are playing a significant role in the market’s expansion. End-use trends are also shaping the market, with hospitals, cancer treatment centers, and specialized radiation oncology clinics being the primary adopters of IMRT. The growing preference for outpatient cancer care has further boosted demand for compact and cost-effective IMRT systems. Meanwhile, advancements in telemedicine and remote treatment planning are enabling wider access to IMRT in underserved areas, addressing geographical disparities in cancer care. Collectively, these factors underscore the strategic importance of IMRT in revolutionizing cancer treatment and meeting the evolving needs of patients and healthcare providers worldwide.

SCOPE OF STUDY:

The report analyzes the Intensity Modulated Radiation Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Radiation Type (Electron Radiation, Carbon-Ion Radiation, Photon Radiation, Proton Radiation); Application (Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application, Brain Cancer Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Accuray, Inc.
  • Brainlab AG
  • Elekta AB
  • IBA Dosimetry GmbH
  • Mevion Medical Systems, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Protom International
  • RAYSEARCH Laboratories AB
  • Reflexion Medical, Inc.
  • Siemens Healthineers AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Intensity Modulated Radiation Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer Fuels Demand for Intensity Modulated Radiation Therapy (IMRT)
    • Advancements in Imaging Technologies Propel Innovation in IMRT Techniques
    • Focus on Precision and Reduced Side Effects Drives Adoption of IMRT
    • Integration with AI and Machine Learning Enhances Treatment Planning in IMRT
    • Increasing Use of IMRT in Pediatric Oncology Expands Applications
    • Focus on Real-Time Tumor Monitoring Strengthens Demand for Adaptive IMRT Solutions
    • Rising Awareness of Patient-Centric Care Drives Growth in Personalized IMRT Treatments
    • Advancements in Linear Accelerator Technologies Boost Efficiency of IMRT Systems
    • Growth in Radiation Therapy Centers Expands Accessibility to IMRT Treatments
    • Focus on Cost-Effective Treatment Options Drives Development of Scalable IMRT Solutions
    • Integration with Proton Therapy Systems Creates New Opportunities for IMRT
    • Rising Adoption of Cloud-Based Platforms Enhances Data-Driven IMRT Planning
    • Emergence of AI-Driven Quality Assurance Systems Improves Accuracy in IMRT Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intensity Modulated Radiation Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Intensity Modulated Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Electron Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Electron Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Carbon-Ion Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Carbon-Ion Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Photon Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Photon Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Proton Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Proton Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Breast Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Prostate Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Gynecological Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Gynecological Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Lung Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Brain Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • JAPAN
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • CHINA
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • EUROPE
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • FRANCE
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 46: France Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: France 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 48: France Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • GERMANY
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Germany 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 52: Germany Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Germany 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • ITALY
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Italy 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • UNITED KINGDOM
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 58: UK Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: UK 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 60: UK Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: UK 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 64: Rest of Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Rest of World 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 72: Rest of World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of World 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030

IV. COMPETITION